10620219

Source:http://linkedlifedata.com/resource/pubmed/id/10620219

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0205170
pubmed:issue	1
pubmed:dateCreated	2000-3-8
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10620219-10844641
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0323470
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Ramipril
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0085-2538
pubmed:author	pubmed-author:HebertL ALA
pubmed:issnType	Print
pubmed:volume	57
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	343-4
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:10620219-Angiotensin Receptor Antagonists, pubmed-meshheading:10620219-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:10620219-Blood Pressure, pubmed-meshheading:10620219-Humans, pubmed-meshheading:10620219-Kidney Diseases, pubmed-meshheading:10620219-Lipids, pubmed-meshheading:10620219-Ramipril, pubmed-meshheading:10620219-Risk Factors, pubmed-meshheading:10620219-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	Renoprotective therapy: how good can it get?
pubmed:publicationType	Clinical Trial, Editorial, Randomized Controlled Trial